Literature DB >> 5004981

Treatment of status epilepticus with a new benzodiazepine more active than diazepam.

H Gastaut, J Courjon, R Poiré, M Weber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5004981     DOI: 10.1111/j.1528-1157.1971.tb04928.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


× No keyword cloud information.
  7 in total

1.  Letter: Use of clonazepam in epilepsy.

Authors:  H L Halliday; J F Glasgow
Journal:  Br Med J       Date:  1975-12-13

Review 2.  Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's Overview.

Authors:  Martin J Brodie
Journal:  CNS Drugs       Date:  2017-02       Impact factor: 5.749

Review 3.  Recent progress in epilepsy. Diagnostic procedures and treatment.

Authors:  B R Tharp
Journal:  Calif Med       Date:  1973-07

Review 4.  Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes.

Authors:  E Rey; J M Tréluyer; G Pons
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

5.  Clonazepam: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1976-11       Impact factor: 9.546

6.  Clinical considerations in transitioning patients with epilepsy from clonazepam to clobazam: a case series.

Authors:  Raman Sankar; Steve Chung; Michael Scott Perry; Ruben Kuzniecky; Saurabh Sinha
Journal:  J Med Case Rep       Date:  2014-12-16

Review 7.  Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability.

Authors:  Adam Strzelczyk; Laurent M Willems; Ricardo Kienitz; Lara Kay; Isabelle Beuchat; Sarah Gelhard; Sophie von Brauchitsch; Catrin Mann; Alexandra Lucaciu; Jan-Hendrik Schäfer; Kai Siebenbrodt; Johann-Philipp Zöllner; Susanne Schubert-Bast; Felix Rosenow
Journal:  CNS Drugs       Date:  2022-08-16       Impact factor: 6.497

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.